Sanofi articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/08/20 02:02
2014/08/20 02:02
3h
WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a new capsule-based drug to treat Gaucher's disease. Regulators approved the new drug, Cerdelga, for patients with the Type 1...
2014/08/20 02:02
2014/08/20 02:02
Latest videos
2014/08/20 00:37
2014/08/20 00:37
4h
Allergan approaches Salix to fight Valeant bid Published: 20 August 2014 The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec in this file photo from May 20,...
2014/08/19 22:38
2014/08/19 22:38
6h
Older people are likely to benefit from a high-dose flu vaccine to ward off the seasonal malaise, which can be particularly dangerous to those over 65, researchers say. The findings in the New...
2014/08/19 21:17
2014/08/19 21:17
7h
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has approved Cerdelga™ (eliglustat)...
2014/08/19 18:41
2014/08/19 18:41
10h
Shanghai-based drug development firm ZAI Lab announced that it has signed into a global licensing agreement with Sanofi to obtain rights to two novel compounds which are potential treatments for...
2014/08/19 15:18
2014/08/19 15:18
13h
... is a great time for venture capital investments in innovative technologies that are tackling big, unmet problems in healthcare," said Brian Gallagher, Partner at SR One. "Many recent exits and...
2014/08/19 14:50
2014/08/19 14:50
14h
U.S. clears AstraZeneca over heart drug trial LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc (AZN.L) over a major clinical trial used to win marketing approval for its important...
2014/08/19 07:17
2014/08/19 07:17
21h
Probi (STO:PROB) SECOND QUARTER OF 2014 •NET SALES amounted to MSEK 31.9 (26.5). •OPERATING PROFIT totalled MSEK 5.3 (4.6). •PROFIT AFTER TAX amounted to MSEK4.3 (3.8). •PROFIT AFTER TAX PER...
2014/08/19 05:08
2014/08/19 05:08
23h
The U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar™ (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes...
2014/08/19 01:52
2014/08/19 01:52
1d
Bug-killer: Streptomyces coelicolor, the bacteria from which scientists created the antibiotic Streptomycin. – Reuters Understanding the genetic coding also opens up the possibility of developing...
2014/08/18 17:47
2014/08/18 17:47
1d
... lack of an Ebola cure amid the deadliest outbreak in the disease’s history is highlighting a significant challenge in the public health world: developing life-saving cures to those who need them...
2014/08/18 13:59
2014/08/18 13:59
1d
NEW YORK (CNNMoney) - Leonard Schleifer is a billionaire and CEO of Regeneron, one of the top biotech companies in the world.His success was hardly assured when he founded the company. He went through...
2014/08/15 18:31
2014/08/15 18:31
4d
High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a...
2014/08/15 14:22
2014/08/15 14:22
4d
MannKind signed a $925 million licensing pact with French drug maker Sanofi this week to sell its diabetes drug Afrezza. Afrezza is an inhaled powder that works faster than conventional injected forms...
2014/08/15 14:05
2014/08/15 14:05
4d
SENATOR Eric Abetz’s comments linking abortion with breast cancer are an insult to all women, says acting Greens Leader Adam Bandt. Senator Abetz appeared on Channel 10 program The Project last night...
2014/08/15 10:15
2014/08/15 10:15
4d
The U.S. Navy received patents for more inventions last year than two-thirds of the Fortune 500 corporations and government agencies ranked in a report published last month. The Department of the...
2014/08/15 02:08
2014/08/15 02:08
5d
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for...
2014/08/14 14:26
2014/08/14 14:26
5d
Suvorexant, a drug seeking approval from the F.D.A., was inspired by research on narcoleptic dogs.Credit Photograph by Kenji Aoki. One evening in late May, four senior employees of Merck, the...
2014/08/14 10:06
2014/08/14 10:06
5d
The stock soared above $50 a handful of times since going public in 2000, and fell below $10 just as often as InterMune worked on developing the first treatment for a rare fatal lung disease. Now,...
2014/08/14 07:34
2014/08/14 07:34
5d
Heath Kelly writes: Tuesday’s reports suggesting a particularly severe flu season could easily be overstating the case. The figures, released by Influenza Specialist Group say there have been more...
2014/08/20 02:02
2014/08/20 02:02
Latest from Twitter